Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database.
Nguyen LS, Dolladille C, Drici MD, Fenioux C, Alexandre J, Mira JP, Moslehi JJ, Roden DM, Funck-Brentano C, Salem JE. Nguyen LS, et al. Among authors: drici md. Circulation. 2020 Jul 21;142(3):303-305. doi: 10.1161/CIRCULATIONAHA.120.048238. Epub 2020 May 22. Circulation. 2020. PMID: 32442023 Free PMC article. No abstract available.
Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes.
Funck-Brentano C, Salem JE, Nguyen LS, Drici MD, Roden DM. Funck-Brentano C, et al. Among authors: drici md. Arch Cardiovasc Dis. 2020 May;113(5):367-368. doi: 10.1016/j.acvd.2020.04.001. Epub 2020 Apr 15. Arch Cardiovasc Dis. 2020. PMID: 32331979 Free PMC article. No abstract available.
"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
Gérard A, Romani S, Fresse A, Viard D, Parassol N, Granvuillemin A, Chouchana L, Rocher F, Drici MD; French Network of Pharmacovigilance Centers. Gérard A, et al. Among authors: drici md. Therapie. 2020 Jul-Aug;75(4):371-379. doi: 10.1016/j.therap.2020.05.002. Epub 2020 May 7. Therapie. 2020. PMID: 32418730 Free PMC article.
French Pharmacovigilance Public System and COVID-19 Pandemic.
Grandvuillemin A, Drici MD, Jonville-Bera AP, Micallef J, Montastruc JL; French Pharmacovigilance Network. Grandvuillemin A, et al. Among authors: drici md. Drug Saf. 2021 Apr;44(4):405-408. doi: 10.1007/s40264-020-01034-y. Epub 2020 Dec 28. Drug Saf. 2021. PMID: 33372244 Free PMC article.
110 results